| Dr Elizabeth A Poi, MD | |
|
2402 Winnebago St, Madison, WI 53704-5341 | |
| (608) 242-6855 | |
| (608) 242-6848 |
| Full Name | Dr Elizabeth A Poi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 2402 Winnebago St, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043317290 | NPI | - | NPPES |
| 34028000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 49024-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Wi Hospitals & Clinics Authority | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Wisconsin Medical Foundation Inc | 6608785464 | 2164 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
Head and neck cancer patients who reported poor sleep quality one year after diagnosis had more symptoms of chronic pain and complaints of dry mouth related to radiation treatments, according to a recent study from the University of Michigan Comprehensive Cancer Center.
The U.S. Food and Drug Administration today approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.
Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).
› Verified 5 days ago
| Entity Name | University Of Wisconsin Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
Head and neck cancer patients who reported poor sleep quality one year after diagnosis had more symptoms of chronic pain and complaints of dry mouth related to radiation treatments, according to a recent study from the University of Michigan Comprehensive Cancer Center.
The U.S. Food and Drug Administration today approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.
Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth A Poi, MD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Dr Elizabeth A Poi, MD 2402 Winnebago St, Madison, WI 53704-5341 Ph: (608) 242-6855 |
News Archive
Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
Head and neck cancer patients who reported poor sleep quality one year after diagnosis had more symptoms of chronic pain and complaints of dry mouth related to radiation treatments, according to a recent study from the University of Michigan Comprehensive Cancer Center.
The U.S. Food and Drug Administration today approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.
Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).
› Verified 5 days ago
Parker Hoerz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3434 E Washington Ave, Madison, WI 53704 Phone: 608-443-5480 | |
Rebecca Bull, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 675 W Washington Ave, Madison, WI 53703 Phone: 608-257-9700 | |
George F Leydon Iii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 675 W Washington Ave, Madison, WI 53703 Phone: 608-257-9700 | |
Maria Z Din, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1821 S Stoughton Rd, Madison, WI 53716 Phone: 608-260-6000 Fax: 608-252-8283 | |
Caitlin J Regner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 S Park St, Madison, WI 53715 Phone: 608-263-3111 Fax: 608-263-6663 | |
Danalyn K Rayner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7102 Mineral Point Rd, Madison, WI 53717 Phone: 608-828-7603 Fax: 608-828-7644 | |
Rosa A Gilestra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1821 S Stoughton Rd, Madison, WI 53716 Phone: 608-260-6000 Fax: 608-260-6161 |